The Par-4 tumor suppressor protein in TCL1-induced leukemogenesis

Pharmacology, Toxicology and Pharmaceutical Science

• Leukemia 100%
• Tumor Suppressor Protein 100%
• Leukemogenesis 100%
• Chronic Lymphatic Leukemia 33%
• Solid Malignant Neoplasm 33%
• Chemotherapy 16%
• Hematologic Disease 16%
• Disease Exacerbation 16%
• Breast Cancer 16%
• Hematologic Malignancy 16%
• Carcinogenesis 16%
• Transcription Factors 16%
• Heme 16%
• Diseases 16%
• Cytostatic 16%

Biochemistry, Genetics and Molecular Biology

• Tumor Suppressor Protein 100%
• Programmed Cell Death 100%
• Genetics 9%
• Animal Models 9%
• In Vitro Study 9%
• Myeloid 9%
• Transcription Factors 9%
• Carcinogenesis 9%